Table 2 Clinical characteristics of the study population

Age (years) ^a

10 (2–21)

Male/Female

14/8 (64%/36%)

White

14 (64%)

Black

4 (18%)

Asian

2 (9%)

Latino

1 (5%)

Multiracial

1 (5%)

OI Type I

8 (36%)

OI Type III

7 (32%)

OI Type IV

6 (27%)

OI Type VIII

1 (5%)

Height z-score ^a

− 2.96 (− 12.43–4.16)

Weight z-score ^a

− 1.64 (− 11.89–3.29)

BMI z-score ^a

0.81 (− 0.95–2.51)

Able to ambulate without assistance

14/21 (67%)

Receiving pamidronate

16 (73%)

Receiving zoledronic acid

6 (27%)